154 related articles for article (PubMed ID: 1069555)
1. Immunotherapy of human malignant melanoma with irradiated tumor cells, oral Bacillus Calmette-Guérin, and levamisole.
Shibata HR; Jerry LM; Lewis MG; Mansell PW; Capek A; Marquis G
Ann N Y Acad Sci; 1976; 277(00):355-66. PubMed ID: 1069555
[No Abstract] [Full Text] [Related]
2. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma.
Pinsky CM; Hirshaut Y; Wanebo HJ; Fortner JG; Miké V; Schottenfeld D; Oettgen HF
Ann N Y Acad Sci; 1976; 277(00):187-94. PubMed ID: 1069548
[No Abstract] [Full Text] [Related]
4. Immunotherapy of malignant melanoma.
Terry WD
N Engl J Med; 1980 Nov; 303(20):1174-5. PubMed ID: 6999351
[No Abstract] [Full Text] [Related]
5. Effect of administration of BCG, levamisole and irradiated leukemic cells on immune status and remission status in chronic myelogenous leukemia.
Advani SH; Gulwani B; Ghogale SG; Shetye MR; Gangal SG
Oncology; 1985; 42(5):275-81. PubMed ID: 3897932
[TBL] [Abstract][Full Text] [Related]
6. BCG as adjuvant immunotherapy for neoplasia.
Hersh EM; Gutterman JU; Mavligit GM
Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
[No Abstract] [Full Text] [Related]
7. Calmette-Guerin bacillus treatment of experimental conjunctival malignant melanoma.
Rutgard J; Peyman GA; Frenkel M; Saks S
Arch Ophthalmol; 1977 Dec; 95(12):2214-7. PubMed ID: 588117
[TBL] [Abstract][Full Text] [Related]
8. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.
Wile AG; Sparks FC; Morton DL
Cancer Res; 1977 Jul; 37(7 Pt 1):2251-6. PubMed ID: 324610
[TBL] [Abstract][Full Text] [Related]
9. Cancer immunotherapy.
Richman SP; Gutterman JU; Hersh EM
Can Med Assoc J; 1979 Feb; 120(3):322-4, 329. PubMed ID: 371776
[TBL] [Abstract][Full Text] [Related]
10. Effect of bacillus Calmette-Guerin immunotherapy on tumor antigen-induced lymphocyte-stimulated protein synthesis in melanoma patients.
Roth JA; Golub SH; Holmes EC; Morton DL
Surgery; 1975 Jul; 78(1):66-75. PubMed ID: 1138401
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of pulmonary metastases of B16 melanoma with irradiated tumor cells and BCG.
Tai J; Guclu A; Ghose T; Norvell S
Cancer Immunol Immunother; 1983; 15(1):47-53. PubMed ID: 6553507
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma.
Spitler LE
J Invest Dermatol; 1976 Sep; 67(3):435-41. PubMed ID: 787436
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer.
Gutterman JU; Mavligit GM; Blumenshein G; Burgess MA; McBride CM; Hersh EM
Ann N Y Acad Sci; 1976; 277(00):135-59. PubMed ID: 1069546
[No Abstract] [Full Text] [Related]
14. Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.
Quirt IC; Shelley WE; Pater JL; Bodurtha AJ; McCulloch PB; McPherson TA; Paterson AH; Prentice R; Silver HK; Willan AR
J Clin Oncol; 1991 May; 9(5):729-35. PubMed ID: 2016615
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
Hanna MG; Peters LC
Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
[TBL] [Abstract][Full Text] [Related]
16. Inconsistent response of B16 melanoma to BCG immunotherapy.
Kreider JW; Bartlett GL; Purnell DM
J Natl Cancer Inst; 1976 Apr; 56(4):803-10. PubMed ID: 1255799
[TBL] [Abstract][Full Text] [Related]
17. Combined immunotherapy in malignant melanoma. Regression of metastatic lesions in two patients concordant in timing with systemic administration of transfer factor and Bacillus Calmette-Guérin.
Spitler LE; Levin AS; Wybran J
Cell Immunol; 1976 Jan; 21(1):1-19. PubMed ID: 764975
[No Abstract] [Full Text] [Related]
18. Adoptive transfer and specific active immunization of patients with malignant melanoma.
Seigler H; Buckley CE; Sheppard LB; Horne BJ; Shingleton WW
Ann N Y Acad Sci; 1976; 277(00):522-32. PubMed ID: 1069561
[No Abstract] [Full Text] [Related]
19. Oral bacille Calmette Guérin immunostimulation in malignant melanoma.
MacGregor AB; Falk RE; Landi S; Ambus U; Langer B
Surg Gynecol Obstet; 1975 Nov; 141(5):747-54. PubMed ID: 1105837
[TBL] [Abstract][Full Text] [Related]
20. Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.
McCulloch PB; Dent PB; Blajchman M; Muirhead WM; Price RA
Can Med Assoc J; 1977 Jul; 117(1):33-6. PubMed ID: 861909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]